Medizinische Hochschule Hannover (MHH) / Hannover Medical School
University / College
Location:
Hannover,
Germany (DE)
ISNI: 0000000095299877
ROR: https://ror.org/00f2yqf98
Development of brain metastases and survival outcomes upon first-line systemic therapy in BRAF mutant and BRAF wildtype melanoma patients: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG (2022)
Franklin C, Mohr P, Meier F, Weichenthal M, Grimmel-Mann I, Gutzmer R, Utikal JS, et al.
Conference contribution
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG (2022)
Franklin C, Mohr P, Bluhm L, Grimmelmann I, Gutzmer R, Meier F, Garzarolli M, et al.
Conference contribution
Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022)
Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al.
Conference contribution
Predictors of long-term survival of stage IV melanoma patients: a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG (2022)
Placke JM, Mohr P, Bluhm L, Kahler K, Weichenthal M, Meier F, Garzarolli M, et al.
Conference contribution
Therapy Management of the first Recurrence after adjuvant Therapy in Stage III: multicenter real-world Data (2022)
Lodde G, Forschner A, Hassel JC, Wulfken LM, Meier F, Mohr P, Kaehler K, et al.
Conference contribution
Tolerability and efficacy of BRAF and MEK inhibitors for metastasized melanoma after intra-class switch: a multicenter, retrospective study (2022)
Salzmann M, Wald A, Stege H, Loquai C, Zimmer L, Hayani K, Heinzerling L, et al.
Conference contribution
Differences in Stakeholders' Perception of the Impact of COVID-19 on Clinical Care and Decision-Making (2022)
Haier J, Beller J, Adorjan K, Bleich S, De Greck M, Griesinger F, Heppt M, et al.
Journal article
A survey regarding the organizational aspects and quality systems of in-house 3D printing in oral and maxillofacial surgery in Germany (2022)
Zeller AN, Goetze E, Thiem DGE, Bartella AK, Seifert L, Beiglboeck FM, Kroeplin J, et al.
Journal article
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial (2022)
Zimmermann H, Koenecke C, Dreyling MH, Pott C, Duehrsen U, Hahn D, Meidenbauer N, et al.
Journal article
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies (2022)
Arora P, Zhang L, Krüger N, Rocha C, Sidarovich A, Schulz S, Kempf A, et al.
Journal article